Deutsche Bank’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.93M Buy
962,312
+120,076
+14% +$997K ﹤0.01% 1233
2025
Q4
$8.78M Sell
842,236
-125,380
-13% -$1.26M ﹤0.01% 1127
2025
Q3
$8.7M Sell
967,616
-261,646
-21% -$2.3M ﹤0.01% 1097
2025
Q2
$16M Buy
1,229,262
+573,751
+88% +$8.63M 0.01% 889
2025
Q1
$16.6M Sell
655,511
-1,713
-0.3% -$50.9K 0.01% 869
2024
Q4
$22.6M Buy
657,224
+10,634
+2% +$480K 0.01% 814
2024
Q3
$32M Sell
646,590
-151,767
-19% -$7.78M 0.01% 722
2024
Q2
$48M Buy
798,357
+28,323
+4% +$1.62M 0.02% 572
2024
Q1
$39.7M Buy
770,034
+63,640
+9% +$3.12M 0.02% 618
2023
Q4
$28.5M Buy
706,394
+692,630
+5,032% +$20.3M 0.01% 684
2023
Q3
$384K Sell
13,764
-55,367
-80% -$1.65M ﹤0.01% 2335
2023
Q2
$1.99M Buy
69,131
+53,754
+350% +$1.2M ﹤0.01% 1624
2023
Q1
$256K Buy
15,377
+4,901
+47% +$69.2K ﹤0.01% 2887
2022
Q4
$133K Buy
10,476
+136
+1% +$1.65K ﹤0.01% 3192
2022
Q3
$125K Sell
10,340
-1,371
-12% -$18.8K ﹤0.01% 3207
2022
Q2
$165K Buy
11,711
+1,331
+13% +$17.6K ﹤0.01% 3274
2022
Q1
$128K Buy
10,380
+5,318
+105% +$63.8K ﹤0.01% 3490
2021
Q4
$57K Buy
5,062
+270
+6% +$3.25K ﹤0.01% 3922
2021
Q3
$61K Buy
+4,792
New +$66K ﹤0.01% 4062

Other funds holding RXST

Deutsche Bank's RXST Position: Q1 2026 in Review

Deutsche Bank increased its RxSight (RXST) stake by 14% in Q1 2026, buying an estimated $997K and bringing the position to 962,312 shares worth $5.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Deutsche Bank first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $48M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Deutsche Bank held 962,312 shares of RxSight worth $5.93M as of Q1 2026.
  • Deutsche Bank bought 120,076 RxSight shares in Q1 2026, an estimated $997K.
  • RxSight made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1233 holding.
  • Deutsche Bank first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
  • Deutsche Bank's RxSight position peaked at $48M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.